中华胃肠外科杂志
中華胃腸外科雜誌
중화위장외과잡지
Chinese Journal of Gastrointestinal Surgery
2015年
10期
1002-1005
,共4页
蔡永华%黎燕红%邓颖晖%叶俊文%康亮%张兴伟%邓艳红%黄美近
蔡永華%黎燕紅%鄧穎暉%葉俊文%康亮%張興偉%鄧豔紅%黃美近
채영화%려연홍%산영휘%협준문%강량%장흥위%산염홍%황미근
胃肠道肿瘤%化疗%输液港%上臂静脉%锁骨下静脉%并发症
胃腸道腫瘤%化療%輸液港%上臂靜脈%鎖骨下靜脈%併髮癥
위장도종류%화료%수액항%상비정맥%쇄골하정맥%병발증
Gastrointestinal neoplasms%Chemotherapy%Totally implantable venous access ports%Upper arm vein%Subclavian vein%Complications
目的:比较经上臂静脉与锁骨下静脉两种入路完全植入式输液港应用于胃肠肿瘤患者化疗的并发症。方法回顾性分析2013年9月至2015年1月间在中山大学附属第六医院肿瘤内科行输液港植入的208例患者的临床资料,其中上臂静脉入路组86例,锁骨下静脉入路组122例。比较两组患者植入术后早期及远期并发症发生情况。结果所有输液港均成功植入。上臂静脉入路组与锁骨下静脉入路组早期总并发症发生率的差异无统计学意义[22.1%﹙19/86)比17.2%﹙21/122), P=0.38];其中上臂静脉组导管异位的发生率高于锁骨下静脉组[14.0%﹙12/86)比5.7%﹙7/122),P=0.04],但这些异位的导管均可在X线透视下调整到正确位置。上臂静脉入路组远期总并发症发生率明显低于锁骨下静脉组[7.0%﹙6/86)比27.0%﹙33/122),P=0.01);其中上臂静脉组输液不.发生率低于锁骨下静脉组[1.2%﹙1/86)比9.8%﹙12/122),P=0.02]。结论与锁骨下静脉植入方式相比,上臂静脉输液港术后远期并发症更低,是一种安全、舒适的植入方式。
目的:比較經上臂靜脈與鎖骨下靜脈兩種入路完全植入式輸液港應用于胃腸腫瘤患者化療的併髮癥。方法迴顧性分析2013年9月至2015年1月間在中山大學附屬第六醫院腫瘤內科行輸液港植入的208例患者的臨床資料,其中上臂靜脈入路組86例,鎖骨下靜脈入路組122例。比較兩組患者植入術後早期及遠期併髮癥髮生情況。結果所有輸液港均成功植入。上臂靜脈入路組與鎖骨下靜脈入路組早期總併髮癥髮生率的差異無統計學意義[22.1%﹙19/86)比17.2%﹙21/122), P=0.38];其中上臂靜脈組導管異位的髮生率高于鎖骨下靜脈組[14.0%﹙12/86)比5.7%﹙7/122),P=0.04],但這些異位的導管均可在X線透視下調整到正確位置。上臂靜脈入路組遠期總併髮癥髮生率明顯低于鎖骨下靜脈組[7.0%﹙6/86)比27.0%﹙33/122),P=0.01);其中上臂靜脈組輸液不.髮生率低于鎖骨下靜脈組[1.2%﹙1/86)比9.8%﹙12/122),P=0.02]。結論與鎖骨下靜脈植入方式相比,上臂靜脈輸液港術後遠期併髮癥更低,是一種安全、舒適的植入方式。
목적:비교경상비정맥여쇄골하정맥량충입로완전식입식수액항응용우위장종류환자화료적병발증。방법회고성분석2013년9월지2015년1월간재중산대학부속제륙의원종류내과행수액항식입적208례환자적림상자료,기중상비정맥입로조86례,쇄골하정맥입로조122례。비교량조환자식입술후조기급원기병발증발생정황。결과소유수액항균성공식입。상비정맥입로조여쇄골하정맥입로조조기총병발증발생솔적차이무통계학의의[22.1%﹙19/86)비17.2%﹙21/122), P=0.38];기중상비정맥조도관이위적발생솔고우쇄골하정맥조[14.0%﹙12/86)비5.7%﹙7/122),P=0.04],단저사이위적도관균가재X선투시하조정도정학위치。상비정맥입로조원기총병발증발생솔명현저우쇄골하정맥조[7.0%﹙6/86)비27.0%﹙33/122),P=0.01);기중상비정맥조수액불.발생솔저우쇄골하정맥조[1.2%﹙1/86)비9.8%﹙12/122),P=0.02]。결론여쇄골하정맥식입방식상비,상비정맥수액항술후원기병발증경저,시일충안전、서괄적식입방식。
Objective To compare two different routes of totally implantable venous access ports﹙TIVPs) from the upper arm vein and the subclavian vein in terms of complications for patients with gastrointestinal malignancy. Methods Patients who underwent implantations of TIVPs from September 2013 to January 2015 were retrospectively evaluated. The outcome measurements were rates and types of postprocedural early-stage and long-term complications. Results A total of 208 patients﹙upper arm vein group, 86; subclavian vein group, 122) were included in this study. All TIVPs were implanted successfully. The rate of catheter displacement was higher in upper arm vein group ﹙14.0% vs 5.7%, P=0.04), while other postprocedural early-stage complications had no significant difference between the two groups. The occurrence of transfusion obstacle and rates of overall postprocedural long-term complications were significantly lower in upper arm vein group than that in subclavian vein group﹙1.2% vs. 9.8%, P=0.02; 7.0% vs. 27.0%, P=0.01, respectively). Conclusion Compared with subclavian vein group, upper arm vein group has lower postprocedural long-term complication rates and is recommended as a safe and comfortable choice for port implantation.